Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology
NEW YORK, Nov. 21, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Japanese patent for the technology “Protease Inhibitor – Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same” has been granted by […]
